• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Balaxi Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 22472.0
  • ISIN : INE618N01022
47.36 -1 (-1.09%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    47.10

  • Today’s High

    48.35

  • Open

    47.40

  • Perv Close

    47.88

  • 52W Low

    46.19

  • 52W High

    127.45

Key Indicators

  • P/E(TTM)

    72.86

  • Mar.Cap (₹Cr.)

    261.46

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.16

  • Debt-Equity Ratio

    -1.09

  • AGM Date

    01-Aug-2025

  • EPS

    0.65

  • P/E Ratio

    72.86

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    261.46

  • RONW (%)

    -25.94

  • ROCE (%)

    20.69

Score Board

  • Equity (₹ in Cr.)

    11.04

  • BV (₹)

    23.20

  • Sales( ₹ in Cr.)

    60.99

  • NP (in Cr.)

    3.60

  • NP Var(%)

    -2.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    261.46

  • 52 Week High

    127.45

  • 52 Week Low

    46.19

  • Price BSE

    0.0

  • Price NSE

    47.00

  • Market Capital( in Cr.)

    261.46

  • P/C Ratio

    64.00

  • P/E Ratio

    72.10

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 70.20 108.14 101.29 86.87 45.63 13.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 70.20 108.14 101.29 86.87 45.63 13.60
Other Income 2.40 6.60 2.75 1.81 0.59 0.89
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 72.60 114.74 104.04 88.68 46.22 14.49
EXPENDITURE :            
Raw Materials 56.49 82.10 76.92 63.33 32.83 0.00
Power and Fuel Cost 0.04 0.04 0.02 0.00 0.00 0.00
Employee Cost 5.04 4.04 2.90 1.95 1.75 0.90
Other Manufacturing Expenses 0.21 0.25 0.13 0.12 0.00 10.30
Selling and Administration Expenses 2.58 4.51 3.79 2.06 1.71 0.59
Miscellaneous Expenses 0.49 0.33 0.23 0.39 0.69 0.25
Employee Benefit Expenses 5.04 4.04 2.90 1.95 1.75 0.90
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 64.84 91.27 83.99 67.85 36.99 12.04
Operating Profit 7.75 23.48 20.05 20.83 9.24 2.44
Interest 1.66 0.51 0.10 0.15 0.05 0.00
Gross Profit 6.09 22.97 19.95 20.68 9.19 2.44
Depreciation 0.51 0.52 0.25 0.09 0.01 0.00
Profit Before Tax 5.58 22.45 19.70 20.59 9.18 2.44
Current Tax 2.04 5.17 5.00 5.46 2.69 0.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.11 1.06 0.03 0.00 0.00 0.00
Reported Net Profit 3.65 16.22 14.67 15.13 6.50 1.97
Extraordinary Items -0.04 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.69 16.22 14.67 15.13 6.50 1.97
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 52.34 36.61 21.95 6.81 0.32 -1.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.50 0.00 0.00 0.00 0.00
P & L Balance carried down 55.99 52.34 36.61 21.95 6.81 0.32
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 5.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.50 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.35 15.93 14.67 15.13 6.50 6.47
Earnings Per Share(Adj)-Unit Curr 0.67 3.19 2.93 3.03 1.30 1.29
Book Value 108.07 80.35 57.91 43.25 28.11 11.58
Book Value(Adj)-Unit Curr 21.61 16.07 11.58 8.65 5.62 2.32

Shareholding Pattern

  • Promoter Group

    65.99%

  • Public Share Holding

    34.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,000,000 63.40 35,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,431,770 2.59 1,431,770 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 36,431,770 65.99 36,431,770 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 13,160 0.02 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,894,544 8.87 4,894,544 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,907,704 8.89 4,894,544 5
2] Non Institution
Bodies Corporate 2,317,380 4.20 2,317,380 53
Clearing Members 50 0.00 50 1
Directors of their Relatives 1,068,795 1.94 1,068,795 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 201,782 0.37 201,782 111
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 200,571 0.36 200,571 154
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,915,330 3.47 1,915,330 7
Individuals holding nominal share capital up to Rs. 1 lakh 6,997,362 12.67 6,859,912 13,399
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,166,756 2.11 1,166,756 2
Sub Total 13,868,026 25.12 13,730,576 13,729
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 55,207,500 100.00 55,056,890 13,737

Company Background

Balaxi Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Balaxi Pharmaceuticals Ltd
  • BSE Code : 22472.0
  • ISIN : INE618N01022

  • Incorporation Year

    1942

  • Registered Office

    41/298-D2 2nd Flr Saniya Plaza
    Mahakavi Bharatiyar Road, Cochin,
    Kerala-682035

  • Telephone

    91-484-4032952/6596725

  • FAX

  • Chairman

  • Managing Director

    Ashish Maheshwari

  • Company Secretary

    Mohith Kumar Khandelwal

  • Auditor

    P Murali & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    SKDC Consultants Ltd
    Surya 35 Mayflower ,
    Avenue Sowripalayam ,Road
    Mumbai - Coimbatore - 641 028

Balaxi Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Balaxi Pharma 47.36 72.59 70.20 72.86 5.99
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10